03/11/2024
7:31 AM | PHAXIAM Therapeutics S.A. (Filer)
PHAXIAM Therapeutics (Filer)
| Form 15F-12B | |
03/05/2024
11:15 PM | PHAXIAM Therapeutics S.A. (Filer)
PHAXIAM Therapeutics (Filer)
| Form EFFECT | |
03/04/2024
3:28 PM | PHAXIAM Therapeutics S.A. (Filer)
PHAXIAM Therapeutics (Filer)
| Form S-8 POS | |
03/04/2024
3:25 PM | PHAXIAM Therapeutics S.A. (Filer)
PHAXIAM Therapeutics (Filer)
| Form S-8 POS | |
03/04/2024
3:27 PM | PHAXIAM Therapeutics S.A. (Filer)
PHAXIAM Therapeutics (Filer)
| Form S-8 POS | |
03/04/2024
3:14 PM | PHAXIAM Therapeutics S.A. (Filer)
PHAXIAM Therapeutics (Filer)
| Form S-8 POS | |
03/04/2024
3:22 PM | PHAXIAM Therapeutics S.A. (Filer)
PHAXIAM Therapeutics (Filer)
| Form S-8 POS | |
|
03/01/2024
3:04 PM | PHAXIAM Therapeutics S.A. (Filer)
PHAXIAM Therapeutics (Filer)
| Form 25
Notification of the removal from listing and registration of matured, redeemed or retired securities | |
02/21/2024
5:05 AM | PHAXIAM Therapeutics S.A. (Filer)
PHAXIAM Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/19/2024
9:04 AM | PHAXIAM Therapeutics S.A. (Filer)
PHAXIAM Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/16/2023
6:41 AM | PHAXIAM Therapeutics S.A. (Filer)
PHAXIAM Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/25/2023
8:21 AM | PHAXIAM Therapeutics S.A. (Filer)
PHAXIAM Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/11/2023
5:53 AM | PHAXIAM Therapeutics S.A. (Filer)
PHAXIAM Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/05/2023
6:32 AM | PHAXIAM Therapeutics S.A. (Filer)
PHAXIAM Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/26/2023
2:01 PM | PHAXIAM Therapeutics S.A. (Filer)
PHAXIAM Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/21/2023
7:42 AM | PHAXIAM Therapeutics S.A. (Filer)
PHAXIAM Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/18/2023
7:16 AM | PHAXIAM Therapeutics S.A. (Filer)
PHAXIAM Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/15/2023
7:03 AM | PHAXIAM Therapeutics S.A. (Filer)
PHAXIAM Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/07/2023
8:33 AM | PHAXIAM Therapeutics S.A. (Filer)
PHAXIAM Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/30/2023
10:33 AM | PHAXIAM Therapeutics S.A. (Filer)
PHAXIAM Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/29/2023
2:52 PM | PHAXIAM Therapeutics S.A. (Filer)
PHAXIAM Therapeutics (Filer)
| Form 424B3 | |
06/28/2023
7:53 AM | Erytech Pharma S.A. (Filer)
PHAXIAM Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/21/2023
5:09 AM | Erytech Pharma S.A. (Filer)
PHAXIAM Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/15/2023
6:32 AM | Erytech Pharma S.A. (Filer)
PHAXIAM Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/12/2023
9:33 AM | Erytech Pharma S.A. (Filer)
PHAXIAM Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/06/2023
6:29 AM | Erytech Pharma S.A. (Filer)
PHAXIAM Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/26/2023
6:39 AM | Erytech Pharma S.A. (Filer)
PHAXIAM Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/24/2023
3:42 PM | Erytech Pharma S.A. (Subject)
PHAXIAM Therapeutics (Subject)
| Form F-X
Appointment of agent for service of process and undertaking | |
05/24/2023
3:08 PM | Erytech Pharma S.A. (Subject)
PHAXIAM Therapeutics (Subject)
| Form CB
Tender offer/rights offering notification form | |
05/24/2023
7:25 AM | Erytech Pharma S.A. (Filer)
PHAXIAM Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/16/2023
9:14 AM | Erytech Pharma S.A. (Filer)
PHAXIAM Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/10/2023
7:55 AM | Erytech Pharma S.A. (Filer)
PHAXIAM Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
